This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/27/15 - 1:47:35 PM ET (BATS BZX Real-time Price)
Div Yield: --
OSIR Day's Range
OSIR 52 Week Range
OSIR Business Summary
Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States.View OSIR key stats
Osiris Therapeutics Inc - OSIR - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Osiris Therapeutics Inc as a
Hold with a ratings score of C.
Report Snippet: We rate OSIRIS THERAPEUTICS INC (OSIR) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and poor profit margins.